Pioneering Gene Therapies.
Drive gene therapy from discovery to commercialization.
Characterize genes, design modifications, engineer and select delivery vectors, plan clinical trials, scale manufacturing, and manage the full lifecycle. With Genedata.
Our Customers
Vectors. More Precise.
- Characterize diverse delivery systems in high throughput and easily track their quality and performance.
- Investigate variations using automated product or cell line sequencing workflows and verify gene expression profiles post-transfection.
- Optimize upstream processes and enable efficient scale-up, optimized product titers, and better quality.
- Streamline cell banking and develop better fed-batch and perfusion upstream processes, to reduce timelines and costs.
Quality. Seamless.
- Standardize and simplify quality assessment and biosafety testing with advanced NGS data analysis offering a rapid, sensitive, and unbiased approach that requires less biological input.
- Capture all development and CMC data on one central structured platform to harmonize workflows, improve quality, and reduce costs.
- Maintain data integrity and leverage built-in GxP-validation features, including data governance, and access and data handling controls.
- Easily submit your results to regulatory authorities with seamless transition to a validated environment.
Clinical Trials. Integrated.
- Break down data silos to easily retrieve data from a single, secure access point.
- Perfect biomarker discovery, improve patient stratification, and design more targeted clinical trials by combining clinical, multiomics, real world, CDMO and other data with the most powerful analysis tools.
- Generate new scientific insights through multi-modal data integration, ensuring all therapies are delivered to the right patients with precision.
Selected Case Studies
Encoded Therapeutics Accelerates AAV Gene Therapy
“We chose Genedata for its central, scalable platform to collect, track, and interpret data in real-time, enhancing decision-making across our process development organization.” Martin Moorhead, Ph.D., CTO, Encoded Therapeutics.
Immatics Boosts CGT R&D Efficiency
“Genedata Biologics provides our R&D teams with a centralized platform to record and access TCR data in real time, enhancing efficiency across the entire workflow.” Dominik Maurer, Ph.D., VP of Immunology, Immatics.